Trending News
News
News
Almirall and BioFocus Announce Collaboration to Find New Hit Compounds against Key Targets
Targets are related to the treatment of respiratory and inflammatory conditions
News
Midatech receives Regulatory Approval for Clinically Testing Ultra-small Gold Nanoparticles
Midatech Ltd announced it has received Swissmedic approval to start the First-in-Human clinical trial with insulin-coated gold nanoparticles, which will be coordinated through its Swiss subsidiary PharMida AG.
News
Stage II Colon Cancer Recurrence Signature Published in the Journal of Clinical Oncology
The article entitled “Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue” gives detail on the development and validation of a prognostic gene signature in Stage II colon cancer.
News
Starna Scientific Appoints Director
Nathan Hulme has been appointed to help guide the company’s expansion plans.
News
AB SCIEX Acquires Labindia’s Mass Spectrometry Division
The acquisition represents AB SCIEX’s increasing investment in India responding to the growing needs of India’s scientific community.
News
Arrayjet and Fios Genomics Form Strategic Alliance
Arrayjet Ltd and Fios Genomics announce the formation of a strategic alliance that allows both companies to offer a complete, end to end, microarray solution for their customers.
News
Epistem Announces Partnership with The University of Manchester
Partnership will allow Epistem to expand its wound healing models range.
News
MBio Diagnostics Announces Key Journal Publication
Company is developing a diagnostic system that delivers a panel of infectious disease results.
News
License Agreement Between Leica Microsystems, the Max Planck Society and DKFZ
Developing the next Stimulated Emission Depletion microscopy generation.
News
Aquinox Initiates Two Phase IIa Clinical Studies in Airway Inflammation Following Successful Phase I
AQX-1125, a novel oral anti-Inflammatory compound, exhibits desirable properties for continued development.
Advertisement